3Nickenig G,Harrison DG.The AT1-type angiotensin receptor in oxidative stress and atherogenesis ,part I;oxidative stress and atherogenesis.Circulation,2002,105:393-396.
4Cai H,Griending KK,Harrison DG.The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.Trends Pharmacol Sci,2003,25:471-478.
5Strawn WB,Ferrario CM,Mechanisms linking angiotensin Ⅱ and atherogenesis.Curr Opin Lipidol,2002,13:505-512.
6Costanzo A,Moretti F,Burgio VL,et al.Endothelial activation by angiotensin Ⅱ through NF-[kappa]Band p38 pathways:involvement of NF-[KAPPA]B-inducible kinase(NIK),free oxygen radicals,and selective inhibition by aspirin.J Cell Physiol,2003,195:402-410.
7Phillips MI, Kagiyama S. Angiotensin Ⅱ as a proinflammatory mediator.Curr Opin Invest Drugs,2002,3:569- 577.
8Alvarez A, Sanz MJ. Reactive oxygen species mediate angiotensin Ⅱ-induced leukocyte - endothelial cell interactions in vivo. J Leukoc Biol,2001,70:199 - 206.
9Marfinet,Wim a; Kockx,Mark M.a,b Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Current Opinion in Lipidology,2001,12(5) :535 - 541.
10Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR,with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988.2:983- 986.
